References
Hedén P, Olenius M, Tengvar M (2011) Macrolane for breast enhancement: 12-month follow-up. Plast Reconstr Surg 127:850–860
Décision de police sanitaire de l’AFSSAPS (2011) Portant restriction de la mise sur le marché et de l’utilisation des dispositifs médicaux injectables indiqués dans le comblement et l’augmentation des volumes corporels à visée esthétique, Saint- Denis, France.
Garrido I, Leguevaque P, Gangloff D, Mojallal A (2010) The adipose tissue transfer in the mammary parenchyma (part I): review of the literature on modifications of the radiological images. Ann Chir Plast Esthet 55:568–577
Chaput B, De bonnecaze G, Tristant H, Garrido I, Grolleau JL, Chavoin JP (2011) Macrolane®: a too premature indication in breast augmentation: focusing on current knowledge of the product. Ann Chir Plast Esthet 56:17–171
Goisis M, Savoldi A, Guareschi M (2011) Is hyaluronic acid gel a good option for breast augmentation? Aesthetic Plast Surg 35:134–136
Crawford R, Shrotria S (2011) Macrolane injections for breast enhancement in undiagnosed breast malignancy: a case report. J Plast Reconstr Aesthetic Surg 64:1682–1683
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaput, B., De Bonnecaze, G., Chavoin, J.P. et al. France Prohibits the Use of Macrolane in Aesthetic Breast Augmentation for Reasons Similar to Criticisms of Autologous Fat Grafting to the Breast. Aesth Plast Surg 36, 1000–1001 (2012). https://doi.org/10.1007/s00266-012-9882-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00266-012-9882-5